Showing results (531-540 of 4,932) with videos related to

Sort By:
Pageof 494
Infection and Drug Resistance|February 25, 2022
Distribution and Molecular Characterization of Functional Class 2 Integrons in Clinical Proteus mirabilis IsolatesWenjun Lu, Quedan Qiu, Keda Chen, et al.
Infection and Drug Resistance|February 28, 2022
Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019-February 2020Joana Paixao, Maria Galangue, Celestina Gaston, et al.
Infection and Drug Resistance|February 28, 2022
Synergistic Antimicrobial Effect of Lactiplantibacillus plantarum and Lawsonia inermis Against Staphylococcus aureusDalia Elebeedy, Aml Ghanem, Marwa El-Sayed, et al.
Infection and Drug Resistance|May 1, 2019
Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agentsAli A Ghweil, Mohamad M Helal
Infection and Drug Resistance|April 25, 2019
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort studyXiaoning Wu, Jialing Zhou, Wen Xie, et al.
Infection and Drug Resistance|May 2, 2019
Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in ChinaJing Wang, Yu Pang, Wei Jing, et al.
Infection and Drug Resistance|May 3, 2019
Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolatesJeffrey C Peterson, Heather Durkee, Darlene Miller, et al.
Infection and Drug Resistance|October 16, 2018
Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, NigeriaBarbara Molina-Moya, Saddiq T Abdurrahman, Laura I Madukaji, et al.
Infection and Drug Resistance|September 24, 2021
Traditional Medicine Practice in the Context of COVID-19 Pandemic: Community Claim in Jimma Zone, Oromia, EthiopiaBelachew Umeta Chali, Tsegaye Melaku, Nimona Berhanu, et al.
Infection and Drug Resistance|September 27, 2021
High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort StudyHui Han, Weidong Qin, Yue Zheng, et al.
Pageof 494